Investor Relations

Stock Quote

About SWK Holdings

We are a specialized finance company with a specific focus on opportunities in the global healthcare sector. We provide innovative capital solutions to a broad range of life science companies, institutions and inventors.

We provide capital to our business partners through our own balance sheet as well as through our investment advisory clients, which include family offices and institutional investors. Our broad capital base positions us to be the partner of choice for life science entities looking for flexible, nontraditional sources of capital.

Our management team has extensive experience specifically in healthcare-related principal investing and structured finance, resulting in a deep understanding of business opportunities in the life science sector.

For our investors, we expect to provide superior risk-adjusted returns on capital by investing in marketed ethical product cash flow streams.

Latest News
Jan 03, 2023

Mr. Staggs elevated from "interim" to "permanent" CEO as SWK advances multiple initiatives in 2023 Ms. Dotter joined SWK's Board of Directors in February 2022 DALLAS, Jan. 3, 2023 /PRNewswire/ --...

Nov 16, 2022

SW K Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced the...

Nov 09, 2022

Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET Corporate Highlights Successful leadership transition with Jody Staggs named President and...

View All Releases

Latest Presentation

SWK Corporate Presentation – November 2022

Upcoming & Recent Events
Thursday, November 10, 2022
10:00am - 11:00am EST

View all Events

Contact Us

Jason Rando
Tiberend Strategic Advisors, Inc.
(917) 930-6346


To see news related to SWK Holdings' Portfolio, click here.

Latest Quarterly Results